News & Media

Take a look inside our world

Press Releases

Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advanc...

Teva and Blackstone Life Sciences Announce $400 Million Strategic Growth Capital Agreement to Advance duv

Teva to Present at the Upcoming Investor Conferences in March

Teva to Present at the Upcoming Investor Conferences in March

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Ext...

U.S. Food and Drug Administration (FDA) Accepts Teva’s New Drug Application (NDA) for Olanzapine Extended

Teva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable eff...

Teva and Sanofi’s duvakitug phase 2b maintenance data demonstrated clinically meaningful durable efficacy

Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecu...

Teva Innovative Portfolio and Consistent Execution of Pivot to Growth Strategy Deliver Third Consecutive

Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with ‘Honestly HD’

Will Forte Teams Up with Teva to Get Real About Huntington’s Disease with ‘Honestly HD’

AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and ...

AJOVY® (fremanezumab-vfrm) Significantly Reduced Monthly Migraine and Headache Days in Children and Adole

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Deliv...

Teva to Present at the 44th Annual J.P. Morgan Healthcare Conference: Pivot to Growth Strategy Delivering

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitilig...

Royalty Pharma and Teva Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitilig...

Teva and Royalty Pharma Enter Agreement to Accelerate Development of Potential Treatment for Vitiligo
View all press releases
Previous
Next

Contacts for Media Inquiries

Kelley Dougherty

North America

+1-973-658-0237
Kelley.Dougherty@tevapharm.com

Eden Klein

Israel & Corporate

+972-3-9062645
Eden.Klein@teva.co.il

Fiona Cohen

Europe

fiona.cohen@tevaeu.com

Teva Media Assets

These proprietary media assets are available for download and are intended for non-commercial media use and research only.

Download Logo Download Teva B-Roll

Feature stories

All Access to Medicine Biologics Biosimilars Caregivers Environment Generic Medicines Global Operations Immunology Innovation Leadership Inclusion & Diversity Neuroscience Our People Patient Focus Quality Research & Development Respiratory Sustainability Wellbeing Working at Teva

3 Trends I’m Watching in Clinical Research Studies

3 Trends I’m Watching in Clinical Research Studies

“Real Progress Comes Not from Extraordinary Moments but from the Everyday”

“Real Progress Comes Not from Extraordinary Moments but from the Everyday”

Addressing the Unmet Needs of Inflammatory Bowel Disease Patients

Addressing the Unmet Needs of Inflammatory Bowel Disease Patients

Why Diversity in Clinical Trials is So Important

Why Diversity in Clinical Trials is So Important

3 Trends I’m Watching in Pharmaceutical Marketing and Digital

3 Trends I’m Watching in Pharmaceutical Marketing and Digital

Spreading HOPE: Teva’s Work to Improve Global Access to Medicine

Spreading HOPE: Teva’s Work to Improve Global Access to Medicine

Living With an Invisible Disability: What We All Need to Know

Living With an Invisible Disability: What We All Need to Know

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

Treating the Untreatable: Harnessing Biological Processes to Fight Disease

A Passport to Career Development: A Journey with Teva's R&D Teams

A Passport to Career Development: A Journey with Teva's R&D Teams

The Neuroscience of Inclusion and Diversity: Unlocking High-Impact Team Performance

The Neuroscience of Inclusion and Diversity: Unlocking High-Impact Team Performance
View all stories

Connect with us on social media

Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Follow us on Twitter

Go to twitter.com

View our Social Media Guidelines

Learn more